Senator Mike Braun @SenatorBraun
Promising news for certain DMD patients in this country. I’m glad to see FDA correct course on Vyondys 53 decision. FDA has the authority to grant conditional approval after promising early stage data on safety and efficacy—they should use it more often. https://t.co/WOWmGKQKe8 — PolitiTweet.org